☰

Michael J. Kluk - Publications

Affiliations: 
Pathology and Lab Medicine Weill Cornell Medical College, New York, NY, United States 
Tree Info Similar researchers PubMed Report error

29 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2023 Callegari K, Dash S, Uchida H, Shingai Y, Liu C, Khodarkovskaya A, Lee Y, Ito A, Lopez A, Zhang T, Xiang J, Kluk MJ, Sanchez T. Molecular profiling of the stroke-induced alterations in the cerebral microvasculature reveals promising therapeutic candidates. Proceedings of the National Academy of Sciences of the United States of America. 120: e2205786120. PMID 37058487 DOI: 10.1073/pnas.2205786120  0.502
2019 Al-Kawaaz M, Sanchez T, Kluk MJ. Evaluation of S1PR1, pSTAT3, S1PR2, FOXP1 Expression in Aggressive, Mature B Cell Lymphomas. Journal of Hematopathology. 12: 57-65. PMID 31404445 DOI: 10.1007/S12308-019-00354-Y  0.587
2017 Ryan RJH, Petrovic J, Rausch DM, Zhou Y, Lareau CA, Kluk MJ, Christie AL, Lee WY, Tarjan DR, Guo B, Donohue LKH, Gillespie SM, Nardi V, Hochberg EP, Blacklow SC, et al. A B Cell Regulome Links Notch to Downstream Oncogenic Pathways in Small B Cell Lymphomas. Cell Reports. 21: 784-797. PMID 29045844 DOI: 10.1016/J.Celrep.2017.09.066  0.368
2016 Bernasconi-Elias P, Hu T, Jenkins D, Firestone B, Gans S, Kurth E, Capodieci P, Deplazes-Lauber J, Petropoulos K, Thiel P, Ponsel D, Hee Choi S, LeMotte P, London A, Goetcshkes M, ... ... Kluk MJ, et al. Characterization of activating mutations of NOTCH3 in T-cell acute lymphoblastic leukemia and anti-leukemic activity of NOTCH3 inhibitory antibodies. Oncogene. PMID 27157619 DOI: 10.1038/Onc.2016.133  0.331
2016 Drier Y, Cotton MJ, Williamson KE, Gillespie SM, Ryan RJ, Kluk MJ, Carey CD, Rodig SJ, Sholl LM, Afrogheh AH, Faquin WC, Queimado L, Qi J, Wick MJ, El-Naggar AK, et al. An oncogenic MYB feedback loop drives alternate cell fates in adenoid cystic carcinoma. Nature Genetics. PMID 26829750 DOI: 10.1038/Ng.3502  0.315
2016 Ryan RJ, Petrovic J, Rausch D, Lareau C, Lee W, Donohue L, Christie AL, Gillespie S, Kluk MJ, Nardi V, Faryabi RB, Hochberg EP, Weinstock DM, Bernstein BE, Aster JC, et al. Notch-Regulated Enhancers in B-Cell Lymphoma Activate MYC and Potentiate B-Cell Receptor Signaling Blood. 128: 457-457. DOI: 10.1182/Blood.V128.22.457.457  0.399
2016 Ryan RJ, Petrovic J, Rausch DM, Lee W, Kluk M, Donohue L, Gillespie S, Aster JC, Pear WS, Bernstein BE. Abstract 886: Notch signaling activates B-cell specific enhancers to drive oncogene targets in B-cell lymphoma Cancer Research. 76: 886-886. DOI: 10.1158/1538-7445.Am2016-886  0.404
2016 Stiles BM, Nasar A, Hussein MK, Ghaly GR, Ahmed MR, Port JL, Lee PC, Nguyen AB, Shostak E, Borczuk AC, Kluk MJ, Altorki NK. Routine molecular testing of resected early-stage lung adenocarcinoma with targeted next-generation sequencing demonstrates a high rate of actionable mutations Journal of Thoracic Oncology. 11: S44-S45. DOI: 10.1016/J.Jtho.2015.12.075  0.329
2015 Kim GS, Yang L, Zhang G, Zhao H, Selim M, McCullough LD, Kluk MJ, Sanchez T. Critical role of sphingosine-1-phosphate receptor-2 in the disruption of cerebrovascular integrity in experimental stroke. Nature Communications. 6: 7893. PMID 26243335 DOI: 10.1038/Ncomms8893  0.559
2015 Carey CD, Gusenleitner D, Chapuy B, Kovach AE, Kluk MJ, Sun HH, Crossland RE, Bacon CM, Rand V, Dal Cin P, Le LP, Neuberg D, Sohani AR, Shipp MA, Monti S, et al. Molecular classification of MYC-driven B-cell lymphomas by targeted gene expression profiling of fixed biopsy specimens. The Journal of Molecular Diagnostics : Jmd. 17: 19-30. PMID 25468432 DOI: 10.1016/J.Jmoldx.2014.08.006  0.301
2014 Gerhardt DM, Pajcini KV, D'altri T, Tu L, Jain R, Xu L, Chen MJ, Rentschler S, Shestova O, Wertheim GB, Tobias JW, Kluk M, Wood AW, Aster JC, Gimotty PA, et al. The Notch1 transcriptional activation domain is required for development and reveals a novel role for Notch1 signaling in fetal hematopoietic stem cells. Genes & Development. 28: 576-93. PMID 24637115 DOI: 10.1101/Gad.227496.113  0.321
2014 Knoechel B, Roderick JE, Williamson KE, Zhu J, Lohr JG, Cotton MJ, Gillespie SM, Fernandez D, Ku M, Wang H, Piccioni F, Silver SJ, Jain M, Pearson D, Kluk MJ, et al. An epigenetic mechanism of resistance to targeted therapy in T cell acute lymphoblastic leukemia. Nature Genetics. 46: 364-70. PMID 24584072 DOI: 10.1038/Ng.2913  0.328
2014 Grayson AR, Walsh EM, Cameron MJ, Godec J, Ashworth T, Ambrose JM, Aserlind AB, Wang H, Evan GI, Kluk MJ, Bradner JE, Aster JC, French CA. MYC, a downstream target of BRD-NUT, is necessary and sufficient for the blockade of differentiation in NUT midline carcinoma Oncogene. 33: 1736-1742. PMID 23604113 DOI: 10.1038/Onc.2013.126  0.324
2014 Knoechel B, Roderick J, Williamson K, Zhu J, Lohr J, Cotton M, Gillespie S, Fernandez D, Ku M, Wang H, Piccioni F, Silver S, Jain M, Pearson D, Kluk M, et al. Abstract 4782: Epigenetic resistance to Notch inhibition in T cell acute lymphoblastic leukemia Cancer Research. 74: 4782-4782. DOI: 10.1158/1538-7445.Am2014-4782  0.328
2013 Kluk MJ, Ashworth T, Wang H, Knoechel B, Mason EF, Morgan EA, Dorfman D, Pinkus G, Weigert O, Hornick JL, Chirieac LR, Hirsch M, Oh DJ, South AP, Leigh IM, et al. Gauging NOTCH1 Activation in Cancer Using Immunohistochemistry. Plos One. 8: e67306. PMID 23825651 DOI: 10.1371/Journal.Pone.0067306  0.324
2013 Zhang G, Yang L, Kim GS, Ryan K, Lu S, O'Donnell RK, Spokes K, Shapiro N, Aird WC, Kluk MJ, Yano K, Sanchez T. Critical role of sphingosine-1-phosphate receptor 2 (S1PR2) in acute vascular inflammation. Blood. 122: 443-55. PMID 23723450 DOI: 10.1182/Blood-2012-11-467191  0.638
2013 Kluk MJ, Ryan KP, Wang B, Zhang G, Rodig SJ, Sanchez T. Sphingosine-1-phosphate receptor 1 in classical Hodgkin lymphoma: assessment of expression and role in cell migration. Laboratory Investigation; a Journal of Technical Methods and Pathology. 93: 462-71. PMID 23419711 DOI: 10.1038/Labinvest.2013.7  0.634
2013 Walsh EM, Grayson AR, Cameron MJ, Godec J, Ashworth T, Aserlind AB, Wang H, Evan G, Kluk MJ, Bradner JE, Aster JC, French CA. Abstract B39: MYC, a downstream target of BRD-NUT, is necessary and sufficient for the blockade of differentiation in NUT midline carcinoma Molecular Cancer Therapeutics. 12. DOI: 10.1158/1535-7163.Pms-B39  0.32
2012 Kluk MJ, Chapuy B, Sinha P, Roy A, Dal Cin P, Neuberg DS, Monti S, Pinkus GS, Shipp MA, Rodig SJ. Immunohistochemical detection of MYC-driven diffuse large B-cell lymphomas. Plos One. 7: e33813. PMID 22511926 DOI: 10.1371/Journal.Pone.0033813  0.313
2012 Neff T, Sinha AU, Kluk MJ, Zhu N, Khattab MH, Stein L, Xie H, Orkin SH, Armstrong SA. Polycomb repressive complex 2 is required for MLL-AF9 leukemia. Proceedings of the National Academy of Sciences of the United States of America. 109: 5028-33. PMID 22396593 DOI: 10.1073/Pnas.1202258109  0.302
2011 Wang X, Werneck MB, Wilson BG, Kim HJ, Kluk MJ, Thom CS, Wischhusen JW, Evans JA, Jesneck JL, Nguyen P, Sansam CG, Cantor H, Roberts CW. TCR-dependent transformation of mature memory phenotype T cells in mice. The Journal of Clinical Investigation. 121: 3834-45. PMID 21926465 DOI: 10.1172/Jci37210  0.336
2003 Kluk MJ, Colmont C, Wu MT, Hla T. Platelet-derived growth factor (PDGF)-induced chemotaxis does not require the G protein-coupled receptor S1P1 in murine embryonic fibroblasts and vascular smooth muscle cells. Febs Letters. 533: 25-8. PMID 12505153 DOI: 10.1016/S0014-5793(02)03742-0  0.636
2002 Kluk MJ, Hla T. Signaling of sphingosine-1-phosphate via the S1P/EDG-family of G-protein-coupled receptors. Biochimica Et Biophysica Acta. 1582: 72-80. PMID 12069812 DOI: 10.1016/S1388-1981(02)00139-7  0.655
2001 Hla T, Lee MJ, Ancellin N, Paik JH, Kluk MJ. Lysophospholipids--receptor revelations. Science (New York, N.Y.). 294: 1875-8. PMID 11729304 DOI: 10.1126/Science.1065323  0.749
2001 Kluk MJ, Hla T. Role of the sphingosine 1-phosphate receptor EDG-1 in vascular smooth muscle cell proliferation and migration. Circulation Research. 89: 496-502. PMID 11557736 DOI: 10.1161/Hh1801.096338  0.608
2000 Hla T, Lee MJ, Ancellin N, Thangada S, Liu CH, Kluk M, Chae SS, Wu MT. Sphingosine-1-phosphate signaling via the EDG-1 family of G-protein-coupled receptors. Annals of the New York Academy of Sciences. 905: 16-24. PMID 10818438 DOI: 10.1111/J.1749-6632.2000.Tb06534.X  0.716
1999 Lee MJ, Thangada S, Claffey KP, Ancellin N, Liu CH, Kluk M, Volpi M, Sha'afi RI, Hla T. Vascular endothelial cell adherens junction assembly and morphogenesis induced by sphingosine-1-phosphate. Cell. 99: 301-12. PMID 10555146 DOI: 10.1016/S0092-8674(00)81661-X  0.729
1999 Hla T, Lee MJ, Ancellin N, Liu CH, Thangada S, Thompson BD, Kluk M. Sphingosine-1-phosphate: extracellular mediator or intracellular second messenger? Biochemical Pharmacology. 58: 201-7. PMID 10423159 DOI: 10.1016/S0006-2952(99)00086-6  0.729
1999 Hla T, Lee M, Anellin N, Liu CH, Thangada S, Kluk M. EDG-1 family of sphingosine-1-phosphate (SPP) receptors Prostaglandins & Other Lipid Mediators. 59: 93. DOI: 10.1016/S0090-6980(99)90328-3  0.748
Show low-probability matches.